Bharat Biotech International Limited
Bharat Biotech International Limited
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age. | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Recruiting | Phase 2 / Phase 3 | 2026-04-29 | NCT07555392 | |
| Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease, tuberculosis | Active, not recruiting | Phase 2 | 2026-04-29 | NCT06997367 | |
| The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants | Rotavirus Infection of Children | Active, not recruiting | Phase 3 | 2025-05-22 | NCT06200844 |